Avalo Therapeutics, Inc.
AVTX
$19.94
-$0.31-1.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.90% | -1.45% | -9.42% | -7.06% | 64.37% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 223.19% | 12.40% | 3.82% | -57.62% | 33.04% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -58.89% | 350.00% | -67.74% | 226.32% | -53.66% |
| Total Current Assets | -7.52% | -1.16% | -9.26% | -8.60% | 61.22% |
|
|
|||||
| Total Current Assets | -7.52% | -1.16% | -9.26% | -8.60% | 61.22% |
| Net Property, Plant & Equipment | -15.13% | -20.99% | -27.71% | -21.51% | -27.78% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 60.31% | 0.00% | 0.00% |
| Total Assets | -6.91% | -1.17% | -8.62% | -8.10% | 53.10% |
|
|
|||||
| Total Accounts Payable | -71.10% | -79.97% | 247.43% | 140.64% | -84.37% |
| Total Accrued Expenses | 83.35% | 19.13% | 54.03% | -29.26% | 45.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -10.50% | -9.13% | -8.37% | -7.39% | 3.27% |
| Total Finance Division Other Current Liabilities | -- | -60.08% | 1.39% | -19.57% | -98.37% |
| Total Other Current Liabilities | -- | -60.08% | 1.39% | -19.57% | -98.37% |
| Total Current Liabilities | 62.32% | -13.90% | 64.90% | -19.32% | -88.53% |
|
|
|||||
| Total Current Liabilities | 62.32% | -13.90% | 64.90% | -19.32% | -88.53% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -70.09% | -40.61% | -28.36% | -21.43% | -67.68% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -19.75% | 102.85% | 25.30% | -3.58% | -25.59% |
| Total Liabilities | -0.43% | 52.45% | 38.35% | -10.12% | -76.62% |
|
|
|||||
| Common Stock & APIC | 0.99% | 3.44% | 0.55% | 0.54% | 41.38% |
| Retained Earnings | -3.16% | -7.58% | -5.42% | -3.55% | -10.55% |
| Treasury Stock & Other | 65.85% | 220.59% | -- | -- | -- |
| Total Common Equity | -9.28% | -12.46% | -14.71% | -7.83% | 531.20% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.28% | -12.46% | -14.71% | -7.83% | 531.20% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.28% | -12.46% | -14.71% | -7.83% | 485.17% |
|
|
|||||